Steadfast in our commitment and support for HCV elimination by 2030.

At AbbVie, we’re supporting people with HCV by identifying and successfully linking them to appropriate care – one at a time.

We are passionate and committed to finding and treating populations considered among the “missing millions” to achieve the WHO’s target of HCV elimination by 2030.

 

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com.

For more information about supporters of the World Hepatitis Alliance visit www.worldhepatitisalliance.org